Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,345
+$123 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3,108
of 3,140 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CBIZ Investment Advisory Services, LLC holds $777,524 across 8 Drug Manufacturers - General names. AMGN ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
406 | $486,968 | |
| 2 | ABBV |
AbbVie Inc.
|
502 | $126,323 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
615 | $77,699 | |
| 4 | JNJ |
Johnson & Johnson
|
163 | $41,397 | |
| 5 | NVS |
Novartis AG
|
167 | $26,172 | |
| 6 | MRK |
Merck & Co., Inc.
|
57 | $7,324 | |
| 7 | PFE |
Pfizer Inc
|
303 | $7,296 | |
| 8 | AMGN |
Amgen Inc
This page
|
12 | $4,345 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,345 | 12 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,222 | 12 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $34,040 | 104 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $22,293 | 79 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,681 | 49 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $28,662 | 92 | Shares | Sole | 2025-06-03 | |
| 2024-12-31 | $1,824 | 7 | Shares | Sole | 2025-02-10 | |
| 2020-03-31 | $6,081 | 30 | Principal | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||